Nurix Therapeutics【NRIX】株式ニュース

名称	銘柄コード	市場	種別
Nurix Therapeutics Inc	NRIX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-1.55	-9.26%	15.18	13:00:07

始値	安値	高値	終値	前日終値
16.51	14.862	16.59	15.18	16.73

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/14	07:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/13	08:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/12	05:06	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2024/6/10	20:00	GLOBE	Nurix Therapeutics to Host a Webcast and Conference Call to..
2024/6/06	07:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/04	07:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/04	05:58	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/29	20:00	GLOBE	Nurix Therapeutics to Participate in the Jefferies Global..
2024/5/28	20:00	GLOBE	Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as..
2024/5/21	20:06	EDGAR2	Form 8-K - Current report
2024/5/21	08:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	08:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	05:00	GLOBE	Nurix Therapeutics Announces Board Chair Transition
2024/5/14	23:00	GLOBE	Nurix Therapeutics Announces Upcoming Oral Presentation of..
2024/5/07	20:00	GLOBE	Nurix Therapeutics to Participate in RBC Capital Markets..
2024/4/17	07:21	GLOBE	Nurix Therapeutics Announces Closing of Public Offering and..
2024/4/12	12:38	GLOBE	Nurix Therapeutics Announces Pricing of Upsized $175.0..
2024/4/12	05:00	GLOBE	Nurix Therapeutics Announces Proposed Public Offering
2024/4/10	20:00	GLOBE	Nurix Therapeutics Reports First Quarter Fiscal 2024..
2024/4/10	02:15	GLOBE	Nurix Therapeutics Reports First Clinical Evidence of CNS..
2024/4/09	20:00	GLOBE	Nurix Therapeutics Announces Extension of Strategic..
2024/4/03	20:00	GLOBE	Nurix Therapeutics to Participate in Upcoming Investor..
2024/4/02	20:00	GLOBE	Nurix Therapeutics Announces Extension of Strategic..
2024/3/25	20:00	GLOBE	Nurix Therapeutics is Part of a Team of International..
2024/3/20	22:40	GLOBE	Nurix Presents the Discovery and Chemical Structure of..
2024/3/11	20:02	EDGAR2	Form 8-K - Current report
2024/3/11	20:00	GLOBE	Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical..
2024/3/07	06:00	GLOBE	Nurix Therapeutics to Participate in Upcoming Investor..
2024/3/06	06:30	GLOBE	Nurix Therapeutics Announces Presentations at the American..
2024/2/17	09:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/17	06:22	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/16	06:51	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/2/16	06:01	EDGAR2	Form 8-K - Current report
2024/2/16	06:00	GLOBE	Nurix Therapeutics Reports Fourth Quarter and Fiscal Year..
2024/2/15	21:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	21:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	21:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/14	22:51	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/02	06:01	GLOBE	Nurix Therapeutics Announces Publication in the Journal..
2024/1/31	08:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/31	08:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/31	08:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/30	06:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/17	06:48	DJN	Nurix Therapeutics Gets FDA Fast-Track Designation for..
2024/1/17	06:01	GLOBE	Nurix Therapeutics Receives U.S. FDA Fast Track Designation..
2024/1/08	21:03	EDGAR2	Form 8-K - Current report
2024/1/08	21:00	GLOBE	Nurix Therapeutics Outlines 2024 Strategic Priorities with..
2024/1/03	06:01	GLOBE	Nurix Therapeutics to Present at 42nd Annual J.P. Morgan..
2023/12/22	07:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..